Sera Prognostics/$SERA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sera Prognostics
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Ticker
$SERA
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
64
Website
Sera Prognostics Metrics
BasicAdvanced
$105M
-
-$0.93
1.00
-
Price and volume
Market cap
$105M
Beta
1
52-week high
$4.39
52-week low
$1.37
Average daily volume
495K
Financial strength
Current ratio
2.021
Quick ratio
1.975
Total debt to equity
0.085
Interest coverage (TTM)
-1,599.48%
Profitability
EBITDA (TTM)
-36
Gross margin (TTM)
8.70%
Net profit margin (TTM)
-28,685.22%
Operating margin (TTM)
-31,989.57%
Management effectiveness
Return on assets (TTM)
-22.10%
Return on equity (TTM)
-41.36%
Valuation
Price to revenue (TTM)
860.681
Price to book
1.1
Price to tangible book (TTM)
1.12
Price to free cash flow (TTM)
-3.648
Free cash flow yield (TTM)
-27.42%
Free cash flow per share (TTM)
-0.762
Growth
Revenue change (TTM)
-44.17%
Earnings per share change (TTM)
-13.56%
3-year revenue growth (CAGR)
2.43%
3-year earnings per share growth (CAGR)
-20.38%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sera Prognostics stock?
Sera Prognostics (SERA) has a market cap of $105M as of August 01, 2025.
What is the P/E ratio for Sera Prognostics stock?
The price to earnings (P/E) ratio for Sera Prognostics (SERA) stock is 0 as of August 01, 2025.
Does Sera Prognostics stock pay dividends?
No, Sera Prognostics (SERA) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Sera Prognostics dividend payment date?
Sera Prognostics (SERA) stock does not pay dividends to its shareholders.
What is the beta indicator for Sera Prognostics?
Sera Prognostics (SERA) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.